Skip Navigation


Nancy M.P. King, J.D.Wake Forest School of Medicine

Nancy M.P. King, J.D.


Contact Information

Academic: 336-716-4289 | Department: 336-716-4289


Education & Training

  • B.A., St Johns College, 1975
  • J.D., University of North Carolina School of Law, 1980
Nancy M.P. King, J.D.

Nancy M.P. King, J.D.

Professor, Social Sciences & Health Policy
Institute for Regenerative Medicine

Research Interests

Informed Consent; Human Experimentation; Research Subjects; Clinical Trials as Topic; Biomedical Research
More »

Contact Information

Academic: 336-716-4289 | Department: 336-716-4289


Recent Publications

Healthcare providers' roles in decision making about tracheostomy for children with medical complexity [abstract]. Nageswaran S, Golden S, Gower W, King N.. J Pain Symptom Manage. 2018;55(2):693-694.

Ensuring respect for persons in COMPASS: a cluster randomised pragmatic clinical trial. Andrews JE, Moore JB, Weinberg RB, Sissine M, Gesell S, Halladay J, Rosamond W, Bushnell C, Jones S, Means P, King NMP, Omoyeni D, Duncan PW.. J Med Ethics. 2018;():.

New treatments for serious conditions: ethical implications. King NMP, Bishop CE.. Gene Ther. 2017;24(9):534-538.

Performable case studies in ethics education. Robeson R, King NMP.. Healthcare (Basel). 2017;5(3):E57.

Ethical considerations in tissue engineering research: case studies in translation. Baker HB, McQuilling JP, King NM.. Methods. 2016;99():135-144.

Conscience, courage, and 'consent' [editorial]. Hall MA, King NM.. Hastings Cent Rep. 2016;46(2):30-32.

The importance of amicable and productive disagreement [editorial]. King NM.. J Med Philos. 2015;40(3):286-288.

ASGCT and JSGT joint position statement on human genomic editing [commentary]. Friedmann T, Jonlin EC, King NM, Torbett BE, Wivel NA, Kaneda Y, Sadelain M.. Mol Ther. 2015;23(8):1282.

Informed consent for research on medical practices [letter]. Shepherd L, Macklin R, King NM, Dreger A, Wages NA.. Ann Intern Med. 2015;163(9):725.

Moral entanglements: the ancillary-care obligations of medical researchers [book review]. King NMP.. J Moral Philos. 2015;12(6):787-789.

Ethics in regenerative medicine and transplantation. King NMP. In: Orlando G, ed. Regenerative medicine applications in organ transplantation. Amsterdam; Boston: Elsevier Academic Press;2014: 977-986.

Early-stage research: issues in design and ethics. King NMP. In: Hogle LF, ed. Regenerative medicine ethics: governing research and knowledge practices. New York: Springer;2014: 187-204.

Privacy and confidentiality in research. King NMP, Iltis AS. In: Jennings B, ed. Bioethics. 4th ed. Farmington Hills (MI): Macmillan Reference;2014: 2503-2513.

Ethical issues in stem cell research and therapy. King NMP, Perrin J.. Stem Cell Res Ther. 2014;5():85.

Commentary on Wilson et al. King NMP.. Clin Trials. 2014;11(5):530-531.

Cell-based interventions in utero: time to reconsider. King NMP, Iltis AS.. Front Pharmacol. 2014;5():214.

Faith in science: professional and public discourse on regenerative medicine. Keys T, King NMP, Atala A. In: Hyde MJ, Herrick JA, eds. After the genome: a language for our biotechnological future. Waco (TX): Baylor University Press;2013: 11-40.

Athletes are Guinea pigs [commentary]. King NMP, Robeson R.. Am J Bioeth. 2013;13(10):13-14.

Perceptions regarding genetic testing in populations at risk for nephropathy [abstract]. Freedman BI, Fletcher AJ, Sanghani VR, Graham A, Bailey JNC, Iltis A, King NMP.. J Am Soc Nephrol. 2013;24(Abstract Suppl):658A.

There's a lot we don't know (and we ought to say so) [commentary]. King NMP.. Am J Bioeth. 2013;13(12):20-21.

'Why we should continue to worry about the therapeutic misconception'. Churchill LR, King NMP, Henderson GE.. J Clin Ethics. 2013;24(4):381-386.

Perceptions regarding genetic testing in populations at risk for nephropathy. Freedman BI, Fletcher AJ, Sanghani VR, Spainhour M, Graham AW, Russell GB, Cooke Bailey JN, Iltis AS, King NMP.. Am J Nephrol. 2013;38(6):453-457.

The OHRP and SUPPORT--another view [letter]. Macklin R, Shepherd L, Dreger A, Asch A, Baylis F, Brody H, Churchill LR, Coleman CH, Cowan E, Dolgin J, Downie J, Dresser R, Elliott C, Epright MC, Feder EK, Glantz LH, Grodin MA, Hoffman W, Hoffmaster B, Hunter D, Iltis AS, Kahn JD, King NM, Kraft R,.. N Engl J Med. 2013;369(2):e3.

Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy. Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Freidmann T, Dunbar C, Aiuti A, Naldini L, Baum C, von Kalle C, Kiem H-P, Montini E, Bushman F, Sorrentino BP, Carrondo M,.. Mol Ther. 2012;20(6):1084-1094.

Research is care [letter]. King NMP.. Hastings Cent Rep. 2012;42(3):7.

Advance care planning and end-of-life decision-making. King NMP, Moskop JC. In: Hester DM, Schonfeld T, eds. Guidance for healthcare ethics committees. Cambridge (UK): Cambridge University Press;2012: 80-87.

Overlapping ethical issues in cell and gene therapies [abstract]. King NM.. Hum Gene Ther. 2012;23(10):A24.

Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field. Fatehi L, Wolf SM, McCullough J, Hall R, Lawrenz F, Kahn JP, Jones C, Campbell SA, Dresser RS, Erdman AG, Haynes CL, Hoerr RA, Hogle LF, Keane MA, Khushf G, King NM, Kokkoli E, Marchant G, Maynard AD, Philbert M, Ramachandran G, Siegel RA, Wickline S.. J Law Med Ethics. 2012;40(4):716-750.

What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M... J Law Med Ethics. 2012;40(4):1008-1024.

Bad blood thirty years later: a Q&A with James H. Jones. Jones JH, King NMP.. J Law Med Ethics. 2012;40(4):867-872.

Introduction: research ethics: reexamining key concerns. King NMP, Iltis AS.. J Law Med Ethics. 2012;40(4):865-866.

Nanomedicine first-in-human research: challenges for informed consent. King NMP.. J Law Med Ethics. 2012;40(4):823-830.

Toward a proportionate regulatory framework for gene transfer: a patient group-led initiative. Kent A, King NMP, Cohen-Haguenauer O.. Hum Gene Ther. 2011;22(2):126-134.

Biodefense research and the U.S. regulatory structure whither nonhuman primate moral standing?. Walker RL, King NMP.. Kennedy Inst Ethics J. 2011;21(3):277-310.

Pluripotent stem cells: the search for the 'perfect' source. King NMP, Coughlin CN, Atala A.. Minn J Law Sci Technol. 2011;12(2):715-730.

Communication ethics and bioethics: an interface. Hyde MJ, King NMP.. Rev Commun. 2010;10(2):156-171.

Contextualizing the character-violence equation in sports. Robeson R, King N.. J Study Sports Athletes Educ. 2010;4(2):123-138.

Ethical issues in regenerative medicine. King NMP, Coughlin CN, Furth M.. Wake Forest Intellect Prop Law J. 2010;9(3):215-237.

Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Hall MA, King NMP, Perdue LH, Hilner JE, Akolkar B, Greenbaum CJ, McKeon C.. Clin Trials. 2010;7(1 Suppl):S33-S45.

Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting. Hall MA, Friedman JY, King NMP, Weinfurt KP, Schulman KA, Sugarman J.. Acad Med. 2010;85(10):1554-1556.

When doctors become 'patients': advocating a patient-centered approach for health care workers in the contest of mandatory influenza vaccinations and informed consent. Coughlin CN, King NMP, Kemper K.. Wake Forest Law Rev. 2010;45(5):1551-1563.

Legal methods. Hall MA, King NMP. In: Sugarman J, Sulmasy DP, eds. Methods in medical ethics. 2nd ed. Washington (DC): Georgetown University Press;2010: 127-144.

Ethical issues in lifestyle change and adherence. King NMP. In: Shumaker SA, Ockene JK, Riekert KA, eds. The handbook of health behavior change. 3rd ed. New York: Springer;2009: 757-770.

Pragmatism, value, and judgment in medicine: a review of Means, ends and medical care, philosophy & medicine, vol 92, by H.G. Wright [book review]. King NMP.. J Law Med Ethics. 2009;37(1):147-148.

Benefits, harms, and motives in clinical research [editorial]. King NMP.. Hastings Cent Rep. 2009;39(4):3.

Disclosure of financial relationships to participants in clinical research. Weinfurt KP, Hall MA, King NMP, Friedman JY, Schulman KA, Sugarman J.. N Engl J Med. 2009;361(9):916-621.

Parents' online portrayals of pediatric treatment and research options. Schaffer R, Henderson GE, Churchill LR, King NMP, Rothschild BB, Lohser S, David AM.. J Empir Res Hum Res Ethics. 2009;4(3):73-87.

Biomedical journals, advertising, and conflict of interest [newsletter article]. Kemper KJ, King NMP.. ISMTE Newsl. 2009;2(11):1-5.

Genetic manipulation in regenerative medicine: research ethics reminders and recommendations [abstract]. King NMP.. Hum Gene Ther. 2009;20(11):1378-1379.

Medical student perspectives on the role of spirituality in end-of-life decision making [abstract]. Cline J, Foster J, Strong J, Passmore L, King N, Hite R.. J Investig Med. 2008;56(1):442.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Quick Reference

Request an Appointment
New Patients


Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  26 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.